Delivery Order SPE2DB24D2205-SPE2DB25FEGCT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,389.36 to AmerisourceBergen Drug Corp on July 18, 2025, for Tetracaine 0.5% Steri-Unit Solution in 4mL units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,582.65 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution 4ML, a pharmaceutical product for military medical supply needs. This competitively awarded, firm fixed price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This...
- The Defense Logistics Agency awarded a $2,094.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4-milliliter units. The contract, which represents a child award under AmerisourceBergen's larger federal contract vehicle, is scheduled for completion by September 4, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $2,038.68 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4 milliliter units. This firm fixed price delivery order, executed on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,946.15 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4mL units. This non-competitive, firm fixed-price delivery order was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and serves as a primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4 mL units, with a ceiling value of $1,950.24 and an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a continuation of the company's pharmaceutical supply mission supporting federal medical procurement. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $2,038.68 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4 mL units, with an ultimate completion date of July 28, 2025. This contract award is not set-aside and utilizes firm fixed pricing under a competitive delivery order arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4ml units. This contract, valued at $3,539.90, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is classified as a child contract and executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,392.18 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4mL units, with an ultimate completion date of September 16, 2025. This non-set-aside delivery order will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfilled this...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 0.5% tetracaine sterile solution products. The $1,744.20 award has a period of performance through March 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order falls under a larger indefinite delivery contract (IDC)...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGCTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,194.61 to AmerisourceBergen Drug Corp for the supply of Tetracaine 0.5% Steri-Unit Solution in 4ML quantities. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and was awarded competitively without set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement valued through December 2026 that serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of medications and medical supplies to defense and veteran healthcare systems. The company holds an extensive portfolio of competitively awarded federal contracts with the DLA Medical Supply Chain, covering specialty medications, generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. The Pharmaceutical Prime Vendor Global Program represents a strategic sourcing approach by DLA Troop Support to ensure reliable pharmaceutical supply chains supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and scalable contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/12/25 |